ES2185935T3 - Compuestos antioxidantes. - Google Patents

Compuestos antioxidantes.

Info

Publication number
ES2185935T3
ES2185935T3 ES97920759T ES97920759T ES2185935T3 ES 2185935 T3 ES2185935 T3 ES 2185935T3 ES 97920759 T ES97920759 T ES 97920759T ES 97920759 T ES97920759 T ES 97920759T ES 2185935 T3 ES2185935 T3 ES 2185935T3
Authority
ES
Spain
Prior art keywords
pct
treatment
date nov
sec
prevention
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES97920759T
Other languages
English (en)
Inventor
Markku Ahotupa
Lauri Kangas
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Orion Oyj
Original Assignee
Orion Oyj
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Orion Oyj filed Critical Orion Oyj
Application granted granted Critical
Publication of ES2185935T3 publication Critical patent/ES2185935T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • AIDS & HIV (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Anti-Oxidant Or Stabilizer Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Compositions Of Macromolecular Compounds (AREA)

Abstract

SE PRESENTA UN NUEVO USO DE LOS DERIVADOS HALOGENADOS DEL TRIFENILETILENO PARA HACER DESCENDER LOS NIVELES DE PEROXIDOS LIPIDOS DE LA SANGRE Y PARA LA PREVENCION O EL TRATAMIENTO DE LOS DAÑOS OXIDATIVOS EN LOS TEJIDOS INDUCIDOS POR LA PERIOXIDACION DE LOS LIPIDOS. EL NUEVO USO INCLUYE LA PREVENCION O EL TRATAMIENTO DE LA ARTERIOSCLEROSIS, LESIONES ISQUEMICAS, PSORIASIS, ENFERMEDADES INFLAMATORIAS, TALES COMO LA ENFERMEDAD DEL COLON INFLAMATORIO O ENFERMEDADES CARDIOVASCULARES TALES COMO ENFERMEDADES CARDIACAS CORONARIAS, LESIONES ISQUEMICAS CARDIACAS Y ARRITMIAS CARDIACAS POSISQUEMICAS, O EL TRATAMIENTO DEL SIDA.
ES97920759T 1996-05-02 1997-05-02 Compuestos antioxidantes. Expired - Lifetime ES2185935T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9609171.5A GB9609171D0 (en) 1996-05-02 1996-05-02 Antioxidant compounds

Publications (1)

Publication Number Publication Date
ES2185935T3 true ES2185935T3 (es) 2003-05-01

Family

ID=10793057

Family Applications (1)

Application Number Title Priority Date Filing Date
ES97920759T Expired - Lifetime ES2185935T3 (es) 1996-05-02 1997-05-02 Compuestos antioxidantes.

Country Status (12)

Country Link
US (2) US5929123A (es)
EP (1) EP0910354B1 (es)
JP (1) JP2000510114A (es)
AT (1) ATE226068T1 (es)
AU (1) AU709131B2 (es)
CA (1) CA2253230C (es)
DE (1) DE69716430T2 (es)
ES (1) ES2185935T3 (es)
GB (1) GB9609171D0 (es)
NO (1) NO323592B1 (es)
NZ (1) NZ332348A (es)
WO (1) WO1997041847A1 (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9609171D0 (en) * 1996-05-02 1996-07-03 Orion Yhtymae Oy Antioxidant compounds
US6346547B1 (en) 1999-02-08 2002-02-12 Checkpoint, Genetics, Inc. N-substituted amino acids, antioxidant pharmaceutical compositions containing n-substituted amino acids and methods for preventing cardiovascular diseases and/or preventing and/or treating antioxidant responsive diseases therewith
KR100375159B1 (ko) * 2000-05-16 2003-03-08 김일한 팔미토일 보효소 ａ를 이용한 포유동물의 혈청알부민의 과산화효소 활성을 증가시키는 방법
US20070123490A1 (en) * 2005-11-30 2007-05-31 Yokoyama Wallace H Preventing or reducing oxidative stress or oxidative cell injury
EP2079476B1 (en) * 2006-10-20 2014-05-21 Dow Global Technologies LLC Uses of hydroxypropyl methylcellulose for preventing or treating metabolic syndrome
US20110130360A1 (en) * 2006-10-20 2011-06-02 Dow Global Technologies Inc. Preventing or reducing oxidative stress or oxidative cell injury
JP2009007256A (ja) * 2007-06-26 2009-01-15 Kao Corp Ｎａｄｈ／ｎａｄｐｈオキシダーゼ抑制剤
WO2011052804A1 (en) * 2009-10-30 2011-05-05 Tokyo University Of Science Educational Foundation Administrative Organization Method of delivering agent into target cell

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5491173A (en) * 1982-06-25 1996-02-13 Orion-Yhtyma Oy Tri-phenyl alkene derivatives and their preparation and use
GB9126209D0 (en) * 1991-12-10 1992-02-12 Orion Yhtymae Oy Drug formulations for parenteral use
GB9207437D0 (en) * 1992-04-03 1992-05-20 Orion Yhtymae Oy Topical administration of toremifene and its metabolites
DE4320896A1 (de) * 1993-06-24 1995-01-05 Denecke Rainer Dr Med Vet Präparat zur Therapie und Prophylaxe von Demenz-Erkrankungen
GB9418067D0 (en) * 1994-09-07 1994-10-26 Orion Yhtymae Oy Triphenylethylenes for the prevention and treatment of osteoporosis
GB9609171D0 (en) * 1996-05-02 1996-07-03 Orion Yhtymae Oy Antioxidant compounds

Also Published As

Publication number Publication date
NO323592B1 (no) 2007-06-11
NO985082D0 (no) 1998-10-30
JP2000510114A (ja) 2000-08-08
NO985082L (no) 1998-10-30
CA2253230C (en) 2007-03-13
ATE226068T1 (de) 2002-11-15
DE69716430D1 (de) 2002-11-21
AU709131B2 (en) 1999-08-19
NZ332348A (en) 2000-05-26
US5929123A (en) 1999-07-27
US6204295B1 (en) 2001-03-20
EP0910354A1 (en) 1999-04-28
CA2253230A1 (en) 1997-11-13
AU2702097A (en) 1997-11-26
DE69716430T2 (de) 2003-07-03
GB9609171D0 (en) 1996-07-03
EP0910354B1 (en) 2002-10-16
WO1997041847A1 (en) 1997-11-13

Similar Documents

Publication Publication Date Title
AR035963A1 (es) Compuestos derivados de trifluormetilbenceno utiles como intermedios de los inhibidores de la proteina de transferencia del ester de colesterilo y procedimientos para su preparacion
BR9815039A (pt) Inibição da oxidação de lipoproteìna
PT944631E (pt) Novos derivados substituidos de pirazole para tratamento de doencas cardiovasculares
NO20010203L (no) Diacylhydrazinderivater som integrininhibitorer
ES2185935T3 (es) Compuestos antioxidantes.
DK0888327T3 (da) Benzopyranderivater, som har antagonistisk virkning imod leukotriener
DE69619865D1 (de) Aromatische keto-säure und ihre derivate als inhibitoren der matrix metalloproteinase
ZA909124B (en) Derivatives of aromatic benzoates as inhibitors of esterase-producing micro-organisms
DE69726281D1 (de) Hemmstoff für die gefässneubildung, der den gewebefaktor-inhibitor (tfpi) enthält
ES2164765T3 (es) Heterociclilbenzonitrilos.
RU96112829A (ru) Способ лечения ишемической болезни сердца
NO172640C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive piperazinderivater
NO20012310L (no) Optisk aktiv pyridyl-4H-1,2,4-oksazdiazinderivat og dets anvendelse ved behandling av karsykdommer
BR9612074A (pt) Novos 4-(1h-benzimidazol-2-il)(1,4) diazepanos substituidos úteis para o tratamento de doenças alérgicas
DE69512940D1 (de) N-hydroxy-harnstoff-derivate als entzündunghemmende mittel
PT1334094E (pt) Benzo[b]tiofenos e benzo(d)isotiazoles para diminuir o colesterol
DE69713648D1 (de) Benzopyranderivate und ihre Verwendung zur Behandlung von Herzkrankheiten
ATE218856T1 (de) Aminotetralinderivat zur behandlung von herzkreislauferkrankung
DK0561882T3 (da) Hydroxamsyrederivater, som inhiberer lipoxygenase
DK0426804T3 (da) 2-(2-hydroxy-3-phenoxypropylamino)-ethoxybenzen-derivater
AU4609701A (en) Colouring agent for keratin containing fibres
DE60024114D1 (de) Zusammensetzung zur behandlung von atherosklerose, welche ein statin und ex-vivo behandeltes blut enthält
ID20165A (id) Penggunaan asam 2-(3,4-dimetoksisinamoil)aminobenzoat untuk pembuatan obat untuk pengobatan atau pencegahan restenosis
ATE190845T1 (de) Rektale flunisolid-zubereitung zur behandlung entzündlicher darmerkrankungen
NO903585L (no) Fremgangsmaate for fremstilling av terapeutisk aktive 1,3-oksaziner.